The multi-country outbreak of Salmonella Stanley ST2045 reported in the Communicable disease threats (report, 2- 8 May 2026, Week 19) is still ongoing. The outbreak is predominantly affecting children and young adults, with at least 20 people hospitalized, indicating a significant public health impact. As of 5 June 2026, 83 confirmed cases have been reported with symptom onset between December 2025 and mid-May 2026. In addition, 24 further Salmonella Stanley cases identified in 2026 have not yet been sequenced and may be linked. New cases continue to be identified, suggesting ongoing exposure. Denmark initially detected the outbreak and posted a notification in EpiPulse on 23 March 2026. The cases belong to a tight genetic cluster and have been identified in Austria, Czechia, Denmark, Estonia, France, Germany, Lithuania, the Netherlands, and the United Kingdom. Epidemiological investigations indicate a suspected link to chicken-flavored instant noodles and/or processed chicken products. Some cases reported consuming instant noodles without preparation (i.e., uncooked, just with the seasoning provided). There are currently 19 S. Stanley human isolates clustering in the ECDC’s Molecular Typing Tool (MTT). The isolates are all from 2026 and from three of the European countries that have reported cases in the EpiPulse event. ECDC assessment identification of a tight genetic cluster of Salmonella Stanley ST2045 involving multiple countries. The ECDC reported that the continued identification of new cases suggests ongoing exposure. @ https://www.ecdc.europa.eu/sites/default/files/documents/Communicable-disease-threats-report-week-23-2026.pdf